GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ViroGates AS (OCSE:VIRO) » Definitions » Book Value per Share

ViroGates AS (OCSE:VIRO) Book Value per Share : kr1.04 (As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is ViroGates AS Book Value per Share?

ViroGates AS's book value per share for the quarter that ended in Mar. 2025 was kr1.04.

During the past 12 months, ViroGates AS's average Book Value Per Share Growth Rate was -50.20% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -29.60% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -32.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of ViroGates AS was 116.50% per year. The lowest was -36.40% per year. And the median was -29.75% per year.

ViroGates AS's current price is kr8.24. Its book value per share for the quarter that ended in Mar. 2025 was kr1.04. Hence, today's PB Ratio of ViroGates AS is 7.95.

During the past 9 years, the highest P/B Ratio of ViroGates AS was 389.97. The lowest was 2.00. And the median was 5.75.


ViroGates AS Book Value per Share Historical Data

The historical data trend for ViroGates AS's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ViroGates AS Book Value per Share Chart

ViroGates AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Book Value per Share
Get a 7-Day Free Trial Premium Member Only 7.73 4.00 3.71 2.64 1.40

ViroGates AS Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.08 1.45 1.10 1.40 1.04

Competitive Comparison of ViroGates AS's Book Value per Share

For the Medical Devices subindustry, ViroGates AS's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ViroGates AS's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ViroGates AS's PB Ratio distribution charts can be found below:

* The bar in red indicates where ViroGates AS's PB Ratio falls into.


;
;

ViroGates AS Book Value per Share Calculation

ViroGates AS's Book Value Per Share for the fiscal year that ended in Dec. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(10.80-0.00)/7.73
=1.40

ViroGates AS's Book Value Per Share for the quarter that ended in Mar. 2025 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(8.01-0.00)/7.73
=1.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


ViroGates AS  (OCSE:VIRO) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


ViroGates AS Book Value per Share Related Terms

Thank you for viewing the detailed overview of ViroGates AS's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


ViroGates AS Business Description

Traded in Other Exchanges
N/A
Address
Banevaenget 13, Birkerod, DNK, DK-3460
ViroGates AS is a life science company that develops and sells prognostic products to the healthcare sector. The products are used in hospital emergency services, in particular, to make a clinical decision on hospitalization or discharge of emergency patients. The products can also be used for the prognosis of lifestyle-related diseases such as cardiovascular disease, type 2 diabetes, and cancer. It has developed a product line called suPARnostic to make the suPAR test available as a commercially available test and the ambition is to get the test implemented and used for clinical decision-making.

ViroGates AS Headlines

No Headlines